Table 3.
Treatment group (n = 10) |
Inorganic phosphate (mg/dL) |
Calcium (mg/dL) |
TNF-α
(pg/mL) |
IL-1β
(pg/mL) |
DPD/creatine (nM/mM) |
---|---|---|---|---|---|
Sham | 7.2 ± 0.8 | 7.4 ± 1.3 | 20 ± 2.1b | 23 ± 4.9b | 92 ± 6.1b |
OVX | 7.3 ± 1.2 | 7.7 ± 1.5 | 76 ± 4.3a | 44 ± 5.6a | 148 ± 8.5a |
OVX + E2 | 7.0 ± 1.1 | 7.3 ± 1.7 | 10 ± 1.9b | 18 ± 5.1b | 82 ± 4.1b |
OVX + BCA | 7.1 ± 0.7 | 7.4 ± 1.2 | 11 ± 1.6b | 20 ± 2.3b | 79 ± 5.2b |
Values are expressed as means ± SD. Differences among treatment groups were evaluated using a one-way ANOVA followed by Fisher's test. a P < 0.05, when compared with the Sham groups; b P < 0.05, when compared with the OVX group. OVX: ovariectomized.